Catalyst Wire Dossier Catalyst Wire Dossier

REGN1154

· Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN1154, covering 2014-01-24 to 2014-01-24. Get the full timeline:

Most recent: Clinical Trial Update: Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy Volunteers [Phase 1]

See pricing